The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXlmedia Regulatory News (XLM)

Share Price Information for Xlmedia (XLM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.25
Bid: 12.00
Ask: 12.50
Change: 0.00 (0.00%)
Spread: 0.50 (4.167%)
Open: 12.25
High: 12.25
Low: 12.25
Prev. Close: 12.25
XLM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)

20 Apr 2016 08:30

RNS Number : 7551V
Liberum Capital Limited
20 April 2016
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Liberum Capital Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

XL Media Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Connected party to the offeree

(d) Date dealing undertaken:

19th April 2016

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

No

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

USD 0.000001 ord

 

 

Sale

6000

0.716 GBP

 

0.716 GBP

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

Date of disclosure:

20th April 2016

Contact name:

Lal Channa

Telephone number:

020 3100 2012

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FERGRGDSCDDBGLG
Date   Source Headline
24th Apr 20249:00 amRNSNotice of Results
2nd Apr 20243:53 pmRNSDivestment of Europe and Canada assets completed
27th Mar 20243:00 pmRNSHoldings in Company
21st Mar 202410:50 amRNSDivestment of Europe and Canada assets
8th Feb 20247:00 amRNSTrading Update
6th Feb 20247:00 amRNSExclusive Partnership with Star Tribune
11th Jan 20247:00 amRNSExtension of Strategic Partnership Agreement
9th Jan 20244:12 pmRNSDirectorate Change
8th Jan 20242:00 pmRNSChange of Nominated Adviser and Broker
15th Dec 20237:00 amRNSPre-close Trading Update
28th Sep 20237:00 amRNSResults for the six months ended 30 June 2023
7th Sep 20237:00 amRNSNotice of Results
5th Sep 20237:00 amRNSExclusive Media Partnership
22nd Aug 20237:00 amRNSNew Media Partnership Agreement in North Carolina
27th Jul 20237:00 amRNSTrading Update and Notice of Results
12th Jul 20237:00 amRNSSale of Three European Casino Assets
6th Jun 20237:00 amRNSDisposal of Personal Finance Assets
31st May 20237:00 amRNSXLMedia Extends Partnership with Schneps Media
30th May 20237:00 amRNSDisposal of Personal Finance Assets
26th May 202311:56 amRNSResults of AGM
26th May 20237:00 amRNSAGM Statement
12th May 20232:00 pmRNSGrant of Share Awards
9th May 20237:00 amRNSXLMedia Signs Revenue Share Contract
4th May 20232:35 pmRNSPosting of Annual Report and Notice of AGM
2nd May 20232:30 pmRNSChange of Registered Office
24th Apr 20237:00 amRNSChange of Adviser
30th Mar 20237:00 amRNSFinal Results
20th Mar 20237:00 amRNSNotice of Results & Analyst/Investor Presentations
13th Feb 202311:05 amRNSSecond Price Monitoring Extn
13th Feb 202311:00 amRNSPrice Monitoring Extension
7th Feb 20232:05 pmRNSSecond Price Monitoring Extn
7th Feb 20232:00 pmRNSPrice Monitoring Extension
31st Jan 202311:05 amRNSSecond Price Monitoring Extn
31st Jan 202311:00 amRNSPrice Monitoring Extension
31st Jan 20237:00 amRNSTrading Update
26th Jan 20237:00 amRNSCapital Markets Day
15th Dec 20227:00 amRNSExploration of Sale of PF Division & CMD
7th Dec 20227:00 amRNSDirector Dealings
6th Dec 20227:00 amRNSDirector Dealings
1st Dec 20227:00 amRNSXLMedia Signs Exclusive Newsweek Partnership Deal
12th Oct 20222:00 pmRNSDeparture of CBWG Founders & VP NA Sport Appointed
29th Sep 20227:00 amRNSHalf-year Results
14th Sep 20227:01 amRNSExtension of Strategic Partnership Agreement
14th Sep 20227:00 amRNSNotice of Results & Analyst/Investor Presentations
19th Aug 20227:00 amRNSGrant of Share Awards
27th Jul 202211:05 amRNSSecond Price Monitoring Extn
27th Jul 202211:00 amRNSPrice Monitoring Extension
27th Jul 20227:00 amRNSTrading Update & Notice of Results
1st Jul 20227:00 amRNSDirectorate Change
28th Jun 202211:51 amRNSDirector Share Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.